(Q40471914)

20 September 2017

1 reference

title

Assessing the activity of rheumatoid arthritis. (English)

1 reference

20 September 2017

3

1 reference

20 September 2017

4

1 reference

20 September 2017

Boers M

1

1 reference

20 September 2017

van Riel PL

series ordinal

2

1 reference

20 September 2017

publication date

1 May 1995

1 reference

Bailliere's clinical rheumatology

20 September 2017

published in

1 reference

20 September 2017

volume

9

1 reference

20 September 2017

issue

2

1 reference

20 September 2017

page(s)

305-317

1 reference

Reduced joint counts in rheumatoid arthritis clinical trials

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980192-X

7 January 2021

Which traditional measures should be used in rheumatoid arthritis clinical trials?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980192-X

7 January 2021

Auranofin therapy and quality of life in patients with rheumatoid arthritis. Results of a multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980192-X

7 January 2021

A comparison of health-related quality-of-life measures for rheumatoid arthritis research. The Auranofin Cooperating Group

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980192-X

7 January 2021

Reduced joint count indices in the evaluation of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980192-X

7 January 2021

The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980192-X

7 January 2021

American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980192-X

7 January 2021

Gold Treatment in Rheumatoid Arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980192-X

7 January 2021

Measurement of patient outcome in arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980192-X

7 January 2021

Reduced joint counts in controlled clinical trials in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980192-X

7 January 2021

A simplified twenty-eight-joint quantitative articular index in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980192-X

7 January 2021

Sensitivity of effect variables in rheumatoid arthritis: a meta-analysis of 130 placebo controlled NSAID trials

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980192-X

7 January 2021

Measuring health-related quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980192-X

7 January 2021

Sensitivity to change of the health assessment questionnaire (HAQ) and other clinical and health status measures in rheumatoid arthritis: results of short-term clinical trials and observational studies versus long-term observational studies

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980192-X

7 January 2021

Report of a three-year study on the systemic and articular indexes in rheumatoid arthritis; theoretic and clinical considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980192-X

7 January 2021

Measuring health status in arthritis. The arthritis impact measurement scales.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980192-X

7 January 2021

AIMS2. The Content and Properties of a Revised and Expanded Arthritis Impact Measurement Scales Health Status Questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980192-X

7 January 2021

The McGill Pain Questionnaire: Major properties and scoring methods

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980192-X

7 January 2021

Preliminary criteria for clinical remission in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980192-X

7 January 2021

Validity and reliability of joint indices. A longitudinal study in patients with recent onset rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980192-X

7 January 2021

Therapeutic criteria in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980192-X

7 January 2021

A COMPARISON OF THE ABILITY OF 28 ARTICULAR INDICES TO DETECT AN INDUCED FLARE OF JOINT INFLAMMATION IN RHEUMATOID ARTHRITIS

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980192-X

7 January 2021

Self report functional disability scores and the use of devices: two distinct aspects of physical function in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980192-X

7 January 2021

The acute-phase response in relation to radiographic progression in early rheumatoid arthritis: a prospective study during the first three years of the disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980192-X

7 January 2021

Provisional guidelines for measuring disease activity in clinical trials on rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980192-X

7 January 2021

10.1016/S0950-3579(05)80192-X

Identifiers

DOI

1 reference

20 September 2017

1 reference